Trending
Dushinsky’s Rabsky Group plans nearly 800 units on former Pfizer site
Developer asking for rezoning of two Wallabout St. blocks
The developer working to transform Bushwick’s Rheingold Brewery site into a mammoth rental project is now looking to build a pair of large apartment buildings on the former Pfizer site at the edge of Bedford–Stuyvesant.
Simon Dushinsky’s Rabsky Group has filed an application to rezone a pair of blocks at the Flushing Avenue G-train stop, which would pave the way for a pair of mixed-use buildings, according to papers the developer filed with the Department of City Planning.
The full-block properties at 249 And 334 Wallabout Street, now zoned for manufacturing, would hold two buildings with a total of 622 market-rate units, 155 affordable units and nearly 32,000 square feet of retail. Dushinsky paid $12.8 million in 2012 to buy the properties from Pfizer, the pharmaceutical giant.
The developer, one of the industry’s most mysterious and under-the-radar figures, could not be immediately reached for comment. Rabsky has built some apartment buildings further down Wallabout, but unlike the ODA Architecture-designed buildings at the Rheingold site, these are done in a more modest style.
Like seemingly every part of Brooklyn, this nook of the borough at the edge of Bedford-Stuyvesant and South Williamsburg is seeing its fair share of investment.
Sitting right next to the famed Marcy Houses that hip-hop titan Jay Z grew up in, Dushinsky’s sites are part of a portfolio Pfizer started selling off after it shuttered its Brooklyn headquarters in 2008.
Acumen Capital Partners picked up a 575,000 square-foot building in 2011 and has transformed it into 630 Flushing, an office property catering to small businesses seeking short-term leases and the flexibility to renovate their spaces.
Dushinsky is one of the more active developers in the outer-boroughs, working on the aforementioned Rheingold Brewery site as well as projects in Park Slope, Williamsburg and Long Island City.